Neuroscience Research on Drug Abuse (R01, R21)

Funding Agency:
National Institutes of Health

Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in this FOA are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. An understanding of the basic mechanisms underlying substance use disorders can help to identify targets for prevention and treatment interventions. Research utilizing basic, translational, or clinical approaches is appropriate.

Although this announcement uses the R01 grant mechanism, it runs in parallel with a program announcement of identical scientific scope, PA-18-078, which uses the R21 grant mechanism. 


  • R01 Deadlines: Feb. 5, Jun. 5, Oct. 5.
  • R21 Deadlines: Feb. 16, Jun. 16, Oct. 16.
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7.

PA-18-060 Expiration Date: January 8, 2020




Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 5, 2019